Spark Therapeutics Aktie
-
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ironwood Pharmaceuticals | 1,00 % | -14,10 % | 46,62 % | 10,80 % | 46,62 % | -62,77 % | -54,65 % |
| Novocure Ltd | 1,84 % | -14,48 % | -8,30 % | -57,90 % | -8,82 % | -87,64 % | -92,21 % |
| Iovance Biotherapeutics Inc. | -1,78 % | -4,36 % | -7,60 % | -62,41 % | -7,50 % | -70,77 % | -93,92 % |
Kommentare
News
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December
Prediction: Nvidia Stock Could Reach $360 Sooner Than You Think
Nvidia (NASDAQ: NVDA) is transforming from a graphics processing unit (GPU) champion to an artificial intelligence (AI) infrastructure cash engine. Learn about Blackwell, DGX Spark, and DGX Cloud




